

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * sarcomere organization (GO:0045214) | 9.14552554 |
| 2 | muscle filament sliding (GO:0030049) | 8.56875302 |
| 3 | actin-myosin filament sliding (GO:0033275) | 8.56875302 |
| 4 | cardiac myofibril assembly (GO:0055003) | 8.20444644 |
| 5 | myofibril assembly (GO:0030239) | 7.92235574 |
| 6 | regulation of skeletal muscle contraction (GO:0014819) | 7.59416310 |
| 7 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.52251861 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.42551512 |
| 9 | actin-mediated cell contraction (GO:0070252) | 7.08450526 |
| 10 | plasma membrane repair (GO:0001778) | 7.01587758 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.83547277 |
| 12 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.75709771 |
| 13 | cardiac muscle contraction (GO:0060048) | 6.65673692 |
| 14 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.55729415 |
| 15 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.40839042 |
| 16 | cardiac muscle cell development (GO:0055013) | 6.31623053 |
| 17 | regulation of relaxation of muscle (GO:1901077) | 6.05393402 |
| 18 | cardiac cell development (GO:0055006) | 5.93077481 |
| 19 | regulation of actin filament-based movement (GO:1903115) | 5.89882309 |
| 20 | striated muscle contraction (GO:0006941) | 5.89300586 |
| 21 | * actomyosin structure organization (GO:0031032) | 5.78691145 |
| 22 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.78611710 |
| 23 | tricarboxylic acid cycle (GO:0006099) | 5.65630733 |
| 24 | adult heart development (GO:0007512) | 5.63933187 |
| 25 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.55852825 |
| 26 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.54620298 |
| 27 | carnitine shuttle (GO:0006853) | 5.54244859 |
| 28 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.52889177 |
| 29 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.51782915 |
| 30 | cardiac muscle hypertrophy (GO:0003300) | 5.40282140 |
| 31 | actin filament-based movement (GO:0030048) | 5.35591402 |
| 32 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.22283479 |
| 33 | striated muscle hypertrophy (GO:0014897) | 5.19081010 |
| 34 | regulation of cell communication by electrical coupling (GO:0010649) | 5.18356563 |
| 35 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.07072497 |
| 36 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.06845373 |
| 37 | skeletal muscle fiber development (GO:0048741) | 5.06782901 |
| 38 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.05291566 |
| 39 | muscle tissue morphogenesis (GO:0060415) | 5.04932626 |
| 40 | regulation of striated muscle contraction (GO:0006942) | 5.03742994 |
| 41 | skeletal muscle contraction (GO:0003009) | 5.03228495 |
| 42 | regulation of sarcomere organization (GO:0060297) | 4.84254183 |
| 43 | fatty acid transmembrane transport (GO:1902001) | 4.74528653 |
| 44 | myotube cell development (GO:0014904) | 4.73464877 |
| 45 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.61999971 |
| 46 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.60684443 |
| 47 | muscle hypertrophy (GO:0014896) | 4.58530731 |
| 48 | heart contraction (GO:0060047) | 4.56695353 |
| 49 | heart process (GO:0003015) | 4.56695353 |
| 50 | heart trabecula formation (GO:0060347) | 4.56644602 |
| 51 | regulation of membrane repolarization (GO:0060306) | 4.56313434 |
| 52 | cell communication involved in cardiac conduction (GO:0086065) | 4.46910209 |
| 53 | regulation of the force of heart contraction (GO:0002026) | 4.29828752 |
| 54 | creatine metabolic process (GO:0006600) | 4.29429914 |
| 55 | regulation of coenzyme metabolic process (GO:0051196) | 4.17053079 |
| 56 | regulation of cofactor metabolic process (GO:0051193) | 4.17053079 |
| 57 | skeletal muscle tissue development (GO:0007519) | 4.16401960 |
| 58 | skeletal muscle adaptation (GO:0043501) | 4.15211317 |
| 59 | response to inactivity (GO:0014854) | 4.14376339 |
| 60 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.13945003 |
| 61 | carnitine transmembrane transport (GO:1902603) | 4.09464809 |
| 62 | muscle contraction (GO:0006936) | 4.08739953 |
| 63 | cardiac muscle cell action potential (GO:0086001) | 4.01833479 |
| 64 | regulation of cardiac muscle contraction (GO:0055117) | 3.97302209 |
| 65 | striated muscle cell development (GO:0055002) | 3.97084804 |
| 66 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.95984234 |
| 67 | cell communication by electrical coupling (GO:0010644) | 3.94281077 |
| 68 | regulation of heart rate (GO:0002027) | 3.82799554 |
| 69 | glucan catabolic process (GO:0009251) | 3.81168119 |
| 70 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.80112339 |
| 71 | muscle adaptation (GO:0043500) | 3.79914670 |
| 72 | negative regulation of protein localization to cell surface (GO:2000009) | 3.79575866 |
| 73 | skeletal muscle tissue regeneration (GO:0043403) | 3.78625300 |
| 74 | muscle system process (GO:0003012) | 3.78448768 |
| 75 | positive regulation of myotube differentiation (GO:0010831) | 3.76921425 |
| 76 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.76403083 |
| 77 | striated muscle adaptation (GO:0014888) | 3.74648413 |
| 78 | muscle atrophy (GO:0014889) | 3.73295679 |
| 79 | regulation of ATP catabolic process (GO:1903289) | 3.72699044 |
| 80 | regulation of ATPase activity (GO:0043462) | 3.72699044 |
| 81 | carnitine transport (GO:0015879) | 3.72389989 |
| 82 | amino-acid betaine transport (GO:0015838) | 3.72389989 |
| 83 | negative regulation of potassium ion transport (GO:0043267) | 3.70762469 |
| 84 | muscle organ development (GO:0007517) | 3.69644419 |
| 85 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.69225855 |
| 86 | muscle hypertrophy in response to stress (GO:0003299) | 3.69225855 |
| 87 | cardiac muscle adaptation (GO:0014887) | 3.69225855 |
| 88 | muscle structure development (GO:0061061) | 3.68008759 |
| 89 | muscle cell cellular homeostasis (GO:0046716) | 3.65092163 |
| 90 | positive regulation of cation channel activity (GO:2001259) | 3.64261518 |
| 91 | muscle cell fate commitment (GO:0042693) | 3.61523316 |
| 92 | 2-oxoglutarate metabolic process (GO:0006103) | 3.61511766 |
| 93 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.58108109 |
| 94 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.58108109 |
| 95 | glucan biosynthetic process (GO:0009250) | 3.57769316 |
| 96 | glycogen biosynthetic process (GO:0005978) | 3.57769316 |
| 97 | cellular polysaccharide catabolic process (GO:0044247) | 3.57684075 |
| 98 | NADH metabolic process (GO:0006734) | 3.57639122 |
| 99 | regulation of heart contraction (GO:0008016) | 3.52945610 |
| 100 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.44917561 |
| 101 | striated muscle atrophy (GO:0014891) | 3.44128604 |
| 102 | oxygen transport (GO:0015671) | 3.44112833 |
| 103 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.44025910 |
| 104 | muscle fiber development (GO:0048747) | 3.43269556 |
| 105 | relaxation of cardiac muscle (GO:0055119) | 3.43049763 |
| 106 | regulation of sequestering of triglyceride (GO:0010889) | 3.42843334 |
| 107 | regulation of muscle contraction (GO:0006937) | 3.42070229 |
| 108 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.41304673 |
| 109 | regulation of sulfur metabolic process (GO:0042762) | 3.40921582 |
| 110 | muscle cell development (GO:0055001) | 3.40361436 |
| 111 | positive regulation of heart rate (GO:0010460) | 3.40314658 |
| 112 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.39989363 |
| 113 | regulation of myoblast differentiation (GO:0045661) | 3.37115394 |
| 114 | response to muscle activity (GO:0014850) | 3.34801610 |
| 115 | cardiac conduction (GO:0061337) | 3.33182554 |
| 116 | regulation of muscle system process (GO:0090257) | 3.31520985 |
| 117 | glycogen catabolic process (GO:0005980) | 3.28810075 |
| 118 | positive regulation of heart contraction (GO:0045823) | 3.27256500 |
| 119 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.25377013 |
| 120 | polysaccharide catabolic process (GO:0000272) | 3.18532223 |
| 121 | regulation of myotube differentiation (GO:0010830) | 3.14609441 |
| 122 | striated muscle tissue development (GO:0014706) | 3.14517907 |
| 123 | response to caffeine (GO:0031000) | 3.13852584 |
| 124 | myoblast fusion (GO:0007520) | 3.13720058 |
| 125 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.13481513 |
| 126 | positive regulation of myoblast differentiation (GO:0045663) | 3.08850082 |
| 127 | response to epinephrine (GO:0071871) | 3.06995243 |
| 128 | myotube differentiation (GO:0014902) | 3.06472649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.92396508 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.52285871 |
| 3 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.06314103 |
| 4 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.06314103 |
| 5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.76633448 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.53602998 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.47519313 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.40947943 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.25324455 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.19968706 |
| 11 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.08837240 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.71095505 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.37392505 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.30237557 |
| 15 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.21422759 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.18484135 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.14397252 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.12244278 |
| 19 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.04722597 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.03137862 |
| 21 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.96969379 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.92090433 |
| 23 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.75602081 |
| 24 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.67514438 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.66418245 |
| 26 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.64442097 |
| 27 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.62979098 |
| 28 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.61279949 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54565704 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50968594 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48448501 |
| 32 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.47643919 |
| 33 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.38306723 |
| 34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35462868 |
| 35 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35334901 |
| 36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31539506 |
| 37 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.29395060 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27278127 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27133475 |
| 40 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24809222 |
| 41 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.24156164 |
| 42 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.24084021 |
| 43 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.23819538 |
| 44 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23228760 |
| 45 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.20954785 |
| 46 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.20581117 |
| 47 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20358508 |
| 48 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20187022 |
| 49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18717887 |
| 50 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.18242384 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17534890 |
| 52 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17219085 |
| 53 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.16827720 |
| 54 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16688917 |
| 55 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16550874 |
| 56 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.14403295 |
| 57 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.13096388 |
| 58 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12623745 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12093338 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10131518 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10070023 |
| 62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09857396 |
| 63 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.09055001 |
| 64 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07730686 |
| 65 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05749808 |
| 66 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05230129 |
| 67 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.04938620 |
| 68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.03720129 |
| 69 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.03589400 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03319642 |
| 71 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.02211387 |
| 72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.01017296 |
| 73 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.00678307 |
| 74 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99742911 |
| 75 | P68_20966046_ChIP-Seq_HELA_Human | 0.99710432 |
| 76 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96790302 |
| 77 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.95936015 |
| 78 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.95936015 |
| 79 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.95611422 |
| 80 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.95301055 |
| 81 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.94721425 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94672558 |
| 83 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94135524 |
| 84 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.94134625 |
| 85 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94126742 |
| 86 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.93308908 |
| 87 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92985631 |
| 88 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.92939747 |
| 89 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91934158 |
| 90 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91101453 |
| 91 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.90643861 |
| 92 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.89678581 |
| 93 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.89636023 |
| 94 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.89578291 |
| 95 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88778377 |
| 96 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88111779 |
| 97 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.87456840 |
| 98 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.86612944 |
| 99 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.86051156 |
| 100 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.85957181 |
| 101 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85267710 |
| 102 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.85176132 |
| 103 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.84769669 |
| 104 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84711636 |
| 105 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.84658849 |
| 106 | GATA1_22025678_ChIP-Seq_K562_Human | 0.84579937 |
| 107 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84349750 |
| 108 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.84131606 |
| 109 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83503168 |
| 110 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.82779570 |
| 111 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.82626248 |
| 112 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.82352174 |
| 113 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.82038897 |
| 114 | SPI1_23127762_ChIP-Seq_K562_Human | 0.81914748 |
| 115 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81669275 |
| 116 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81575911 |
| 117 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.81543696 |
| 118 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81379368 |
| 119 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.80753790 |
| 120 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.80588203 |
| 121 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.80583750 |
| 122 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.80556298 |
| 123 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.80367113 |
| 124 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.80344882 |
| 125 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80301918 |
| 126 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.80058466 |
| 127 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.79578891 |
| 128 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.79522267 |
| 129 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78534944 |
| 130 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.77869769 |
| 131 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.77810179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.87067392 |
| 2 | MP0003646_muscle_fatigue | 6.00193233 |
| 3 | MP0004084_abnormal_cardiac_muscle | 5.25915925 |
| 4 | * MP0000751_myopathy | 4.98064698 |
| 5 | MP0000749_muscle_degeneration | 4.56802223 |
| 6 | MP0004215_abnormal_myocardial_fiber | 4.54118583 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.33118073 |
| 8 | MP0005330_cardiomyopathy | 3.73256486 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.36296525 |
| 10 | * MP0004087_abnormal_muscle_fiber | 3.24836148 |
| 11 | MP0000750_abnormal_muscle_regeneration | 3.07435373 |
| 12 | MP0002972_abnormal_cardiac_muscle | 2.95227301 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.88354645 |
| 14 | * MP0002106_abnormal_muscle_physiology | 2.85999949 |
| 15 | MP0003137_abnormal_impulse_conducting | 2.72382521 |
| 16 | MP0002269_muscular_atrophy | 2.65296238 |
| 17 | MP0008775_abnormal_heart_ventricle | 2.65202345 |
| 18 | MP0004130_abnormal_muscle_cell | 2.64319260 |
| 19 | MP0000747_muscle_weakness | 2.56252698 |
| 20 | MP0010630_abnormal_cardiac_muscle | 2.53027578 |
| 21 | MP0005385_cardiovascular_system_phenoty | 2.41917890 |
| 22 | MP0001544_abnormal_cardiovascular_syste | 2.41917890 |
| 23 | MP0004484_altered_response_of | 2.34364313 |
| 24 | * MP0005369_muscle_phenotype | 2.32943814 |
| 25 | * MP0000759_abnormal_skeletal_muscle | 2.31862472 |
| 26 | MP0006138_congestive_heart_failure | 2.14339245 |
| 27 | MP0004510_myositis | 2.11892272 |
| 28 | MP0003828_pulmonary_edema | 1.95873651 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.91083949 |
| 30 | MP0004085_abnormal_heartbeat | 1.88156399 |
| 31 | MP0004233_abnormal_muscle_weight | 1.85918427 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.66467994 |
| 33 | MP0002127_abnormal_cardiovascular_syste | 1.61713564 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.61346864 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.50507999 |
| 36 | MP0005666_abnormal_adipose_tissue | 1.48915193 |
| 37 | MP0005670_abnormal_white_adipose | 1.31908565 |
| 38 | MP0004270_analgesia | 1.23632261 |
| 39 | MP0001661_extended_life_span | 1.21292196 |
| 40 | MP0003567_abnormal_fetal_cardiomyocyte | 1.13597329 |
| 41 | MP0002108_abnormal_muscle_morphology | 1.12232708 |
| 42 | MP0004185_abnormal_adipocyte_glucose | 1.12088935 |
| 43 | MP0000343_altered_response_to | 1.09782188 |
| 44 | MP0002234_abnormal_pharynx_morphology | 1.09064093 |
| 45 | MP0000266_abnormal_heart_morphology | 1.08581870 |
| 46 | MP0000733_abnormal_muscle_development | 1.04506397 |
| 47 | MP0005375_adipose_tissue_phenotype | 1.02945221 |
| 48 | MP0010368_abnormal_lymphatic_system | 0.97591312 |
| 49 | MP0005165_increased_susceptibility_to | 0.92172345 |
| 50 | MP0003279_aneurysm | 0.91955113 |
| 51 | MP0006035_abnormal_mitochondrial_morpho | 0.91930288 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 0.82991449 |
| 53 | MP0005266_abnormal_metabolism | 0.81628572 |
| 54 | MP0002128_abnormal_blood_circulation | 0.75985816 |
| 55 | MP0005623_abnormal_meninges_morphology | 0.69519396 |
| 56 | MP0000230_abnormal_systemic_arterial | 0.68337671 |
| 57 | MP0002971_abnormal_brown_adipose | 0.67789573 |
| 58 | MP0003566_abnormal_cell_adhesion | 0.67531055 |
| 59 | MP0000013_abnormal_adipose_tissue | 0.64233781 |
| 60 | MP0002822_catalepsy | 0.61607723 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 0.59012613 |
| 62 | MP0005275_abnormal_skin_tensile | 0.57828403 |
| 63 | MP0000003_abnormal_adipose_tissue | 0.57724430 |
| 64 | MP0000767_abnormal_smooth_muscle | 0.56206641 |
| 65 | MP0001879_abnormal_lymphatic_vessel | 0.55933715 |
| 66 | MP0005451_abnormal_body_composition | 0.54555705 |
| 67 | MP0002909_abnormal_adrenal_gland | 0.54129789 |
| 68 | MP0003045_fibrosis | 0.50508563 |
| 69 | MP0003879_abnormal_hair_cell | 0.49125468 |
| 70 | MP0005187_abnormal_penis_morphology | 0.47657637 |
| 71 | MP0008961_abnormal_basal_metabolism | 0.46949182 |
| 72 | MP0010030_abnormal_orbit_morphology | 0.46471561 |
| 73 | MP0005409_darkened_coat_color | 0.46235172 |
| 74 | MP0008438_abnormal_cutaneous_collagen | 0.45858325 |
| 75 | MP0002249_abnormal_larynx_morphology | 0.45710117 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 0.45669040 |
| 77 | MP0004043_abnormal_pH_regulation | 0.45036181 |
| 78 | MP0004147_increased_porphyrin_level | 0.44871921 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 0.42921114 |
| 80 | MP0002925_abnormal_cardiovascular_devel | 0.42583677 |
| 81 | MP0004134_abnormal_chest_morphology | 0.41425207 |
| 82 | MP0002114_abnormal_axial_skeleton | 0.39785518 |
| 83 | MP0004272_abnormal_basement_membrane | 0.39250516 |
| 84 | MP0005334_abnormal_fat_pad | 0.34484296 |
| 85 | MP0005423_abnormal_somatic_nervous | 0.34024625 |
| 86 | MP0001784_abnormal_fluid_regulation | 0.33786384 |
| 87 | MP0000762_abnormal_tongue_morphology | 0.33638375 |
| 88 | MP0003948_abnormal_gas_homeostasis | 0.33433720 |
| 89 | MP0002896_abnormal_bone_mineralization | 0.33018815 |
| 90 | MP0001614_abnormal_blood_vessel | 0.32212206 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.31253755 |
| 92 | MP0004858_abnormal_nervous_system | 0.30348019 |
| 93 | MP0003984_embryonic_growth_retardation | 0.28704042 |
| 94 | MP0004381_abnormal_hair_follicle | 0.28445248 |
| 95 | MP0002009_preneoplasia | 0.27955899 |
| 96 | MP0005535_abnormal_body_temperature | 0.27844420 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.27591587 |
| 98 | MP0002088_abnormal_embryonic_growth/wei | 0.27559091 |
| 99 | MP0001943_abnormal_respiration | 0.27532260 |
| 100 | MP0009115_abnormal_fat_cell | 0.26358819 |
| 101 | MP0009780_abnormal_chondrocyte_physiolo | 0.25050635 |
| 102 | MP0000579_abnormal_nail_morphology | 0.24648885 |
| 103 | MP0001849_ear_inflammation | 0.23796797 |
| 104 | MP0003091_abnormal_cell_migration | 0.22912128 |
| 105 | MP0009384_cardiac_valve_regurgitation | 0.22101875 |
| 106 | MP0004197_abnormal_fetal_growth/weight/ | 0.21954652 |
| 107 | MP0009250_abnormal_appendicular_skeleto | 0.21769786 |
| 108 | MP0005595_abnormal_vascular_smooth | 0.20471075 |
| 109 | MP0002118_abnormal_lipid_homeostasis | 0.20224593 |
| 110 | MP0005452_abnormal_adipose_tissue | 0.19886857 |
| 111 | MP0001299_abnormal_eye_distance/ | 0.19108147 |
| 112 | MP0001958_emphysema | 0.17842791 |
| 113 | MP0008569_lethality_at_weaning | 0.16937533 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.16752777 |
| 115 | MP0002970_abnormal_white_adipose | 0.16730895 |
| 116 | MP0005083_abnormal_biliary_tract | 0.16447919 |
| 117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.16418063 |
| 118 | MP0001727_abnormal_embryo_implantation | 0.16345601 |
| 119 | MP0001853_heart_inflammation | 0.16159972 |
| 120 | MP0005386_behavior/neurological_phenoty | 0.16021424 |
| 121 | MP0004924_abnormal_behavior | 0.16021424 |
| 122 | MP0009672_abnormal_birth_weight | 0.15550518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.92139723 |
| 2 | Calf muscle hypertrophy (HP:0008981) | 6.90637059 |
| 3 | Exercise-induced myalgia (HP:0003738) | 6.72226733 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.61840197 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 6.47011891 |
| 6 | Muscle fiber splitting (HP:0003555) | 6.45447499 |
| 7 | Ventricular tachycardia (HP:0004756) | 6.26422600 |
| 8 | Abnormality of the calf musculature (HP:0001430) | 5.65561046 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 5.51692090 |
| 10 | Atrial fibrillation (HP:0005110) | 5.34313874 |
| 11 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.12256320 |
| 12 | Subaortic stenosis (HP:0001682) | 5.12256320 |
| 13 | Primary atrial arrhythmia (HP:0001692) | 4.99337260 |
| 14 | Myoglobinuria (HP:0002913) | 4.94843343 |
| 15 | Lipoatrophy (HP:0100578) | 4.93344206 |
| 16 | Supraventricular tachycardia (HP:0004755) | 4.82661828 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 4.81460457 |
| 18 | Muscle fiber inclusion bodies (HP:0100299) | 4.75698737 |
| 19 | Supraventricular arrhythmia (HP:0005115) | 4.73172676 |
| 20 | Right ventricular cardiomyopathy (HP:0011663) | 4.71866823 |
| 21 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.66049785 |
| 22 | Increased connective tissue (HP:0009025) | 4.57822641 |
| 23 | Difficulty running (HP:0009046) | 4.39018881 |
| 24 | Syncope (HP:0001279) | 4.37227248 |
| 25 | Type 1 muscle fiber predominance (HP:0003803) | 4.36863493 |
| 26 | Dilated cardiomyopathy (HP:0001644) | 4.16566810 |
| 27 | Bundle branch block (HP:0011710) | 4.15884916 |
| 28 | Calcaneovalgus deformity (HP:0001848) | 4.02764566 |
| 29 | Prolonged QT interval (HP:0001657) | 4.00083917 |
| 30 | Asymmetric septal hypertrophy (HP:0001670) | 3.98513484 |
| 31 | Myotonia (HP:0002486) | 3.89619590 |
| 32 | Nemaline bodies (HP:0003798) | 3.88925028 |
| 33 | Palpitations (HP:0001962) | 3.87632740 |
| 34 | Rhabdomyolysis (HP:0003201) | 3.84830562 |
| 35 | Ventricular arrhythmia (HP:0004308) | 3.72308596 |
| 36 | Deformed tarsal bones (HP:0008119) | 3.52883735 |
| 37 | Heart block (HP:0012722) | 3.50695306 |
| 38 | Difficulty climbing stairs (HP:0003551) | 3.49186741 |
| 39 | Atrioventricular block (HP:0001678) | 3.38725769 |
| 40 | Absent phalangeal crease (HP:0006109) | 3.34543690 |
| 41 | Abnormal atrioventricular conduction (HP:0005150) | 3.31926771 |
| 42 | Ventricular fibrillation (HP:0001663) | 3.27214319 |
| 43 | Malignant hyperthermia (HP:0002047) | 3.18144374 |
| 44 | Muscle stiffness (HP:0003552) | 3.03457257 |
| 45 | Increased variability in muscle fiber diameter (HP:0003557) | 3.02991370 |
| 46 | Neck muscle weakness (HP:0000467) | 3.02231856 |
| 47 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.99012272 |
| 48 | Distal arthrogryposis (HP:0005684) | 2.94218632 |
| 49 | Abnormal EKG (HP:0003115) | 2.87856242 |
| 50 | Areflexia of lower limbs (HP:0002522) | 2.85209404 |
| 51 | Fetal akinesia sequence (HP:0001989) | 2.82023729 |
| 52 | Abnormal finger flexion creases (HP:0006143) | 2.77966128 |
| 53 | Round ear (HP:0100830) | 2.75161625 |
| 54 | Distal lower limb muscle weakness (HP:0009053) | 2.73912567 |
| 55 | Rimmed vacuoles (HP:0003805) | 2.66861854 |
| 56 | Myopathic facies (HP:0002058) | 2.65647478 |
| 57 | Left ventricular hypertrophy (HP:0001712) | 2.58897884 |
| 58 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.54528631 |
| 59 | Abnormality of the calcaneus (HP:0008364) | 2.51965383 |
| 60 | Limb-girdle muscle atrophy (HP:0003797) | 2.49216287 |
| 61 | Palmoplantar keratoderma (HP:0000982) | 2.45672438 |
| 62 | Testicular atrophy (HP:0000029) | 2.44086692 |
| 63 | Distal lower limb amyotrophy (HP:0008944) | 2.40057365 |
| 64 | EMG: neuropathic changes (HP:0003445) | 2.35671353 |
| 65 | Hyperkalemia (HP:0002153) | 2.35327780 |
| 66 | Muscular dystrophy (HP:0003560) | 2.34177680 |
| 67 | Hypoplastic ischia (HP:0003175) | 2.33232591 |
| 68 | Ketoacidosis (HP:0001993) | 2.30286495 |
| 69 | Weak cry (HP:0001612) | 2.25168240 |
| 70 | Gowers sign (HP:0003391) | 2.24549151 |
| 71 | Generalized muscle weakness (HP:0003324) | 2.23199245 |
| 72 | Slender build (HP:0001533) | 2.20774688 |
| 73 | Hepatic necrosis (HP:0002605) | 2.20172405 |
| 74 | Facial diplegia (HP:0001349) | 2.18768068 |
| 75 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.18596597 |
| 76 | Ulnar deviation of the wrist (HP:0003049) | 2.14095088 |
| 77 | Abnormality of the foot musculature (HP:0001436) | 2.13418465 |
| 78 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.13013628 |
| 79 | Scapular winging (HP:0003691) | 2.12121897 |
| 80 | Acute necrotizing encephalopathy (HP:0006965) | 2.06344693 |
| 81 | Abnormality of the ischium (HP:0003174) | 2.02597554 |
| 82 | Frequent falls (HP:0002359) | 2.02271988 |
| 83 | Foot dorsiflexor weakness (HP:0009027) | 2.02130363 |
| 84 | Waddling gait (HP:0002515) | 2.02111621 |
| 85 | Hypoglycemic coma (HP:0001325) | 2.00164400 |
| 86 | Proximal amyotrophy (HP:0007126) | 1.97478183 |
| 87 | Increased muscle lipid content (HP:0009058) | 1.96387480 |
| 88 | Popliteal pterygium (HP:0009756) | 1.95797384 |
| 89 | Sudden cardiac death (HP:0001645) | 1.93527273 |
| 90 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.92642526 |
| 91 | Hepatocellular necrosis (HP:0001404) | 1.91054314 |
| 92 | Ragged-red muscle fibers (HP:0003200) | 1.91031368 |
| 93 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.90785044 |
| 94 | Conjunctival hamartoma (HP:0100780) | 1.90539197 |
| 95 | Progressive muscle weakness (HP:0003323) | 1.88818857 |
| 96 | Hip contracture (HP:0003273) | 1.87704882 |
| 97 | Lower limb amyotrophy (HP:0007210) | 1.85088742 |
| 98 | Congestive heart failure (HP:0001635) | 1.84072985 |
| 99 | Metatarsus adductus (HP:0001840) | 1.83132393 |
| 100 | Dysmetric saccades (HP:0000641) | 1.83103856 |
| 101 | Dicarboxylic aciduria (HP:0003215) | 1.80997953 |
| 102 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.80997953 |
| 103 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.80309930 |
| 104 | Large for gestational age (HP:0001520) | 1.79762692 |
| 105 | Exercise intolerance (HP:0003546) | 1.78216659 |
| 106 | Abnormality of the neuromuscular junction (HP:0003398) | 1.78189384 |
| 107 | Fatigable weakness (HP:0003473) | 1.78189384 |
| 108 | Acute encephalopathy (HP:0006846) | 1.77152604 |
| 109 | Long clavicles (HP:0000890) | 1.76348143 |
| 110 | Limb-girdle muscle weakness (HP:0003325) | 1.73811046 |
| 111 | Spinal rigidity (HP:0003306) | 1.70787825 |
| 112 | Steppage gait (HP:0003376) | 1.70217922 |
| 113 | Limited hip movement (HP:0008800) | 1.69511597 |
| 114 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.69412339 |
| 115 | Increased intramyocellular lipid droplets (HP:0012240) | 1.69168367 |
| 116 | Mitochondrial inheritance (HP:0001427) | 1.68855029 |
| 117 | Progressive macrocephaly (HP:0004481) | 1.68509760 |
| 118 | Bulbar palsy (HP:0001283) | 1.68248498 |
| 119 | Nonprogressive disorder (HP:0003680) | 1.59976849 |
| 120 | Ulnar deviation of finger (HP:0009465) | 1.47801950 |
| 121 | Aplasia of the musculature (HP:0100854) | 1.45714714 |
| 122 | Easy fatigability (HP:0003388) | 1.44553935 |
| 123 | Type 2 muscle fiber atrophy (HP:0003554) | 1.43849698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.55446422 |
| 2 | TTN | 6.08508576 |
| 3 | PHKG2 | 4.44592826 |
| 4 | PHKG1 | 4.44592826 |
| 5 | DMPK | 3.17271745 |
| 6 | LMTK2 | 3.10730579 |
| 7 | PDK4 | 2.93593089 |
| 8 | PDK3 | 2.93593089 |
| 9 | MUSK | 2.84340683 |
| 10 | MYLK | 2.83775387 |
| 11 | TRIB3 | 2.63410615 |
| 12 | PKN2 | 2.56372118 |
| 13 | PIK3CA | 2.25787027 |
| 14 | BCKDK | 2.11055148 |
| 15 | NEK1 | 2.10917131 |
| 16 | PINK1 | 1.98656822 |
| 17 | EEF2K | 1.91909720 |
| 18 | TIE1 | 1.81465647 |
| 19 | PDK2 | 1.75722818 |
| 20 | STK24 | 1.47047818 |
| 21 | MAP3K7 | 1.37542942 |
| 22 | ZAK | 1.32840704 |
| 23 | MAP2K3 | 1.26808232 |
| 24 | NME1 | 1.26288035 |
| 25 | PIK3CG | 1.25886863 |
| 26 | MAPK12 | 1.20844887 |
| 27 | CAMK2D | 1.19545624 |
| 28 | PRKD1 | 1.19411651 |
| 29 | ILK | 1.10728041 |
| 30 | INSRR | 1.08866817 |
| 31 | PAK3 | 1.05786548 |
| 32 | GRK7 | 1.03306088 |
| 33 | MARK1 | 1.01953715 |
| 34 | MAPKAPK3 | 0.99331936 |
| 35 | RIPK1 | 0.98635221 |
| 36 | PRKAA2 | 0.91031153 |
| 37 | ROCK1 | 0.90356197 |
| 38 | PRKAA1 | 0.90260649 |
| 39 | MARK2 | 0.86183249 |
| 40 | MAP3K5 | 0.81095970 |
| 41 | TRPM7 | 0.79307505 |
| 42 | PKN1 | 0.78393536 |
| 43 | MAP3K3 | 0.77896220 |
| 44 | EPHB1 | 0.77576210 |
| 45 | PRPF4B | 0.77002505 |
| 46 | MAP3K6 | 0.76214215 |
| 47 | CDC42BPA | 0.74649058 |
| 48 | STK4 | 0.72876948 |
| 49 | MAP3K13 | 0.70690402 |
| 50 | SIK1 | 0.63295684 |
| 51 | FLT3 | 0.63044504 |
| 52 | WNK4 | 0.61738638 |
| 53 | PDGFRA | 0.60781248 |
| 54 | MAPK4 | 0.58778282 |
| 55 | DYRK1B | 0.57633301 |
| 56 | CAMK4 | 0.57582790 |
| 57 | STK38L | 0.57275042 |
| 58 | TGFBR2 | 0.56749472 |
| 59 | CCNB1 | 0.55493571 |
| 60 | MOS | 0.55208926 |
| 61 | STK38 | 0.54835435 |
| 62 | DAPK3 | 0.52734153 |
| 63 | ROCK2 | 0.51115690 |
| 64 | SGK2 | 0.50799248 |
| 65 | AKT2 | 0.50232956 |
| 66 | MAPK15 | 0.49354251 |
| 67 | CAMK2A | 0.48207106 |
| 68 | PRKACB | 0.47675746 |
| 69 | ICK | 0.46640283 |
| 70 | WNK1 | 0.46623210 |
| 71 | KSR2 | 0.45938205 |
| 72 | RPS6KC1 | 0.45348303 |
| 73 | RPS6KL1 | 0.45348303 |
| 74 | KDR | 0.43944400 |
| 75 | PTK2B | 0.43858596 |
| 76 | FGFR3 | 0.43260746 |
| 77 | MAP2K1 | 0.42287065 |
| 78 | NLK | 0.42229211 |
| 79 | CAMK1 | 0.41223640 |
| 80 | LIMK1 | 0.40719839 |
| 81 | NEK9 | 0.38997514 |
| 82 | CAMK2B | 0.38547605 |
| 83 | PTK6 | 0.38475126 |
| 84 | PRKACA | 0.37523393 |
| 85 | RPS6KA6 | 0.37505673 |
| 86 | MAPK10 | 0.36731915 |
| 87 | CAMK2G | 0.36688806 |
| 88 | ZAP70 | 0.35378349 |
| 89 | RPS6KB2 | 0.34601139 |
| 90 | MAP2K6 | 0.34579365 |
| 91 | MAP2K4 | 0.34187952 |
| 92 | PRKACG | 0.33639174 |
| 93 | CDK12 | 0.33228642 |
| 94 | PDPK1 | 0.32171028 |
| 95 | SGK223 | 0.32044265 |
| 96 | SGK494 | 0.32044265 |
| 97 | STK11 | 0.30764791 |
| 98 | PRKCE | 0.30615091 |
| 99 | LATS1 | 0.28047876 |
| 100 | MTOR | 0.26887168 |
| 101 | TAOK1 | 0.26187390 |
| 102 | PDK1 | 0.24824744 |
| 103 | RPS6KA1 | 0.24264564 |
| 104 | RPS6KB1 | 0.23779649 |
| 105 | PRKG1 | 0.23643197 |
| 106 | PRKCH | 0.22800748 |
| 107 | MAPK11 | 0.22404023 |
| 108 | TNK2 | 0.22081057 |
| 109 | MST1R | 0.20203922 |
| 110 | CAMK1G | 0.20082974 |
| 111 | SGK1 | 0.19983327 |
| 112 | SGK3 | 0.19554066 |
| 113 | TBK1 | 0.19333695 |
| 114 | RPS6KA3 | 0.19210622 |
| 115 | LATS2 | 0.18815348 |
| 116 | FER | 0.18471589 |
| 117 | MAPK8 | 0.18240443 |
| 118 | MAPK7 | 0.18108145 |
| 119 | RET | 0.17791895 |
| 120 | JAK1 | 0.17784974 |
| 121 | MAP3K10 | 0.17483084 |
| 122 | ERBB3 | 0.16426982 |
| 123 | FGFR4 | 0.15873944 |
| 124 | EPHB2 | 0.15329392 |
| 125 | PRKD3 | 0.15028005 |
| 126 | MARK3 | 0.14809816 |
| 127 | MAP3K1 | 0.14635180 |
| 128 | RPS6KA2 | 0.13451794 |
| 129 | MAP3K11 | 0.12727597 |
| 130 | CAMK1D | 0.11739275 |
| 131 | EPHA3 | 0.10228241 |
| 132 | PDGFRB | 0.10158650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.46535347 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.39022966 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.24377555 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.21129969 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.10675852 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.22488652 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.99585448 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.98933994 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.65284545 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.61108953 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.49140484 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.30707963 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.03413955 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.99937058 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.99175398 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.96298189 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95271561 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.88125505 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.61905060 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.54890948 |
| 21 | Insulin resistance_Homo sapiens_hsa04931 | 1.34339408 |
| 22 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31718984 |
| 23 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.26665550 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.25034968 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.22617179 |
| 26 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.20447704 |
| 27 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.18110553 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.18035790 |
| 29 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.14430784 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09327580 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04488317 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.03238385 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.97730726 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.96087159 |
| 35 | Long-term potentiation_Homo sapiens_hsa04720 | 0.94690928 |
| 36 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.93215293 |
| 37 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.91810055 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87416715 |
| 39 | Focal adhesion_Homo sapiens_hsa04510 | 0.85403457 |
| 40 | Lysine degradation_Homo sapiens_hsa00310 | 0.84729535 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82783259 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75464793 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.75438180 |
| 44 | Tight junction_Homo sapiens_hsa04530 | 0.74160408 |
| 45 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72911554 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71212809 |
| 47 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70052982 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69930902 |
| 49 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68187501 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67720930 |
| 51 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65980286 |
| 52 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63431384 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62269564 |
| 54 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61713107 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 0.59562600 |
| 56 | Renin secretion_Homo sapiens_hsa04924 | 0.59374910 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58882692 |
| 58 | Glioma_Homo sapiens_hsa05214 | 0.58618577 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.57112329 |
| 60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56812316 |
| 61 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56597175 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55968133 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55337399 |
| 64 | Insulin secretion_Homo sapiens_hsa04911 | 0.54109377 |
| 65 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53577644 |
| 66 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.53423317 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.53188181 |
| 68 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52589458 |
| 69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.51988953 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50609800 |
| 71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46767839 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.46319520 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45987839 |
| 74 | Adherens junction_Homo sapiens_hsa04520 | 0.45751435 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45574854 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45408948 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45123428 |
| 78 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.44655312 |
| 79 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42806020 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41920000 |
| 81 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41104653 |
| 82 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39682682 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39566399 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.39455182 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.37320887 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.35872955 |
| 87 | Circadian entrainment_Homo sapiens_hsa04713 | 0.35184199 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33994524 |
| 89 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.33303107 |
| 90 | Peroxisome_Homo sapiens_hsa04146 | 0.32813903 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32643422 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31446224 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27564754 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.27132921 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27119019 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26581875 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.25142734 |
| 98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.24076988 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22897517 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22210896 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18893242 |
| 102 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.18644451 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.18430568 |
| 104 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.18031280 |
| 105 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.16307805 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.13672700 |
| 107 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.13669804 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.13513918 |
| 109 | Gap junction_Homo sapiens_hsa04540 | 0.11982619 |
| 110 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.11129611 |
| 111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.10703416 |
| 112 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.09543535 |
| 113 | Bile secretion_Homo sapiens_hsa04976 | 0.09295257 |
| 114 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.08823814 |
| 115 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.08570760 |
| 116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.07321494 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.06616830 |
| 118 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.05901576 |
| 119 | Taste transduction_Homo sapiens_hsa04742 | 0.04964999 |
| 120 | Salivary secretion_Homo sapiens_hsa04970 | 0.04311909 |
| 121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.01905927 |

